This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Knowing when to switch from passive to active strategies can boost returns. This guide outlines practical signals, costs, and risk considerations.
27,240 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Two real estate ETFs take opposite paths: one spreads bets worldwide, the other bets on the U.S. market. Learn how HA...
Global defense budgets are expanding, driving gains in aerospace and defense equities. The ITA ETF offers access to a...
Planet Labs stock popped today after a standout quarter and optimism about a path to profitability. This article brea...
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
NVIDIA’s GTC 2026 unveiled a broader AI-infrastructure push, signaling that nvidia’s developments were bigger than in...
Raymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
Investors are hoarding cash as volatility climbs and policy signals shift risk expectations. The dash cash only just ...
Quantum computing stocks ionq, Rigetti, and D-Wave have captured investor imaginations with big promises and big vola...
Bitcoin continues its climb for the month, pressing into a critical resistance zone. Traders await a confirmed breako...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
Apple doubles down on returning capital to shareholders with a $100 billion buyback and a dividend hike, while rivals...